drugset / Trial / NCT00541697

Eze/Simva Switch Study in Diabetics (0653A-807)

NCT00541697

Phase 3 Completed 648 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

A study to assess the effectiveness and tolerability of MK0653A and MK0653A versus Atorvastatin in lowering LDL-C levels.

Timeline

Start
2005-01-19
Primary completion
2005-09-28
Completion
2005-10-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 20 mg
Subject Ezetimibe Unknown 10 mg
Subject Simvastatin Small molecule 20 mg
Subject Simvastatin Small molecule 40 mg